CTLA4 and cancer: Above all, our cellular interaction analysis sheds light on the mechanisms underlying the malignant transition from HPV infection to precancer to CC and reveals multiple potential novel therapeutic approaches for CC (Figure 5B), for example, anti‐CTLA4 therapy to prevent immune dysfunction and WNT7B inhibition to block cancer invasion and progression.